Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Evaluation of the transcriptional immune biomarkers in peripheral blood from Warao indigenous associate with the infection by Mycobacterium tuberculosis.

Araujo Z, Palacios A, Enciso-Moreno L, Lopez-Ramos JE, Wide A, Waard JH, Rivas-Santiago B, Serrano CJ, Bastian-Hernandez Y, Castañeda-Delgado JE, Enciso-Moreno JA.

Rev Soc Bras Med Trop. 2019 May 16;52:e20180516. doi: 10.1590/0037-8682-0516-2018.

2.

TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.

Hegazy-Hassan W, Zepeda-Escobar JA, Ochoa-García L, Contreras-Ortíz JME, Tenorio-Borroto E, Barbabosa-Pliego A, Aparicio-Burgos JE, Oros-Pantoja R, Rivas-Santiago B, Díaz-Albiter H, Garg NJ, Vázquez-Chagoyán JC.

Vaccine. 2019 Jan 7;37(2):248-257. doi: 10.1016/j.vaccine.2018.11.041. Epub 2018 Nov 27.

3.

Is effective the hyperbaric oxygen therapy for the treatment of ischemic lower extremity ulcers?-new insights from a multicenter study.

Rivas-Santiago B.

Ann Transl Med. 2018 Jun;6(11):226. doi: 10.21037/atm.2018.04.37. No abstract available.

4.

Identification, Characterization, Immunolocalization, and Biological Activity of Lucilin Peptide.

Téllez GA, Zapata JA, Toro LJ, Henao DC, Bedoya JP, Rivera JD, Trujillo JV, Rivas-Santiago B, Hoyos RO, Castano JC.

Acta Trop. 2018 Sep;185:318-326. doi: 10.1016/j.actatropica.2018.06.003. Epub 2018 Jun 8.

PMID:
29890152
5.

Antimicrobial peptides for the treatment of pulmonary tuberculosis, allies or foes?

Rivas-Santiago B, Torres-Juarez F.

Curr Pharm Des. 2018;24(10):1138-1147. doi: 10.2174/1381612824666180327162357.

PMID:
29589538
6.

Type-2 diabetes alters the basal phenotype of human macrophages and diminishes their capacity to respond, internalise, and control Mycobacterium tuberculosis.

Lopez-Lopez N, Martinez AGR, Garcia-Hernandez MH, Hernandez-Pando R, Castañeda-Delgado JE, Lugo-Villarino G, Cougoule C, Neyrolles O, Rivas-Santiago B, Valtierra-Alvarado MA, Rubio-Caceres M, Enciso-Moreno JA, Serrano CJ.

Mem Inst Oswaldo Cruz. 2018 Feb 19;113(4):e170326. doi: 10.1590/0074-02760170326.

7.

Induction by innate defence regulator peptide 1018 of pro-angiogenic molecules and endothelial cell migration in a high glucose environment.

Marin-Luevano P, Trujillo V, Rodriguez-Carlos A, González-Curiel I, Enciso-Moreno JA, Hancock REW, Rivas-Santiago B.

Peptides. 2018 Mar;101:135-144. doi: 10.1016/j.peptides.2018.01.010. Epub 2018 Jan 17.

PMID:
29353019
8.

RNase 7 but not psoriasin nor sPLA2-IIA associates with Mycobacterium tuberculosis during airway epithelial cell infection.

Torres-Juarez F, Touqui L, Leon-Contreras J, Rivas-Santiago C, Enciso-Moreno JA, Hernández-Pando R, Rivas-Santiago B.

Pathog Dis. 2018 Mar 1;76(2). doi: 10.1093/femspd/fty005.

PMID:
29346642
9.

Vitamin D and L-Isoleucine Promote Antimicrobial Peptide hBD-2 Production in Peripheral Blood Mononuclear Cells from Elderly Individuals.

Castañeda-Delgado JE, Araujo Z, Gonzalez-Curiel I, Serrano CJ, Rivas Santiago C, Enciso-Moreno JA, Rivas-Santiago B.

Int J Vitam Nutr Res. 2016 Feb;86(1-2):56-61. doi: 10.1024/0300-9831/a000423. Epub 2017 Oct 20.

PMID:
29052469
10.

Calcitriol promotes proangiogenic molecules in keratinocytes in a diabetic foot ulcer model.

Trujillo V, Marín-Luevano P, González-Curiel I, Rodríguez-Carlos A, Ramírez-Reyes M, Layseca-Espinosa E, Enciso-Moreno JA, Díaz L, Rivas-Santiago B.

J Steroid Biochem Mol Biol. 2017 Nov;174:303-311. doi: 10.1016/j.jsbmb.2017.10.013. Epub 2017 Oct 16.

PMID:
29042175
11.

lysX gene is differentially expressed among Mycobacterium tuberculosis strains with different levels of virulence.

Montoya-Rosales A, Provvedi R, Torres-Juarez F, Enciso-Moreno JA, Hernandez-Pando R, Manganelli R, Rivas-Santiago B.

Tuberculosis (Edinb). 2017 Sep;106:106-117. doi: 10.1016/j.tube.2017.07.005. Epub 2017 Jul 17.

PMID:
28802397
12.

Concordance between IFNγ gene +874 A/T polymorphism and interferon-γ expression in a TB-endemic indigenous setting.

Araujo Z, Palacios A, Biomon R, Rivas-Santiago B, Serrano CJ, Enciso-Moreno L, López-Ramos JE, Wide A, Jiménez JC, Larrea CF, Enciso-Moreno JA.

Rev Soc Bras Med Trop. 2017 Mar-Apr;50(2):199-207. doi: 10.1590/0037-8682-0398-2016.

13.

LL-37, HNP-1, and HBD2/3 modulate the secretion of cytokines TNF-α, IL-6, IFN-γ, IL-10 and MMP1 in human primary cell cultures.

Medina Santos CE, López Hurtado CN, Rivas Santiago B, Gonzalez-Amaro R, Cataño Cañizales YG, Martínez Fierro ML, Enciso-Moreno JA, García Hernández MH.

Eur Cytokine Netw. 2016 Sep 1;27(3):68-74.

14.

Differences in Cytokine Production during Aging and Its Relationship with Antimicrobial Peptides Production.

Castañeda-Delgado JE, Frausto-Lujan I, González-Curiel I, Montoya-Rosales A, Serrano CJ, Torres-Juarez F, Enciso-Moreno JA, Rivas-Santiago B.

Immunol Invest. 2017 Jan;46(1):48-58. doi: 10.1080/08820139.2016.1212873. Epub 2016 Sep 12.

PMID:
27618158
15.

Glucose levels affect LL-37 expression in monocyte-derived macrophages altering the Mycobacterium tuberculosis intracellular growth control.

Montoya-Rosales A, Castro-Garcia P, Torres-Juarez F, Enciso-Moreno JA, Rivas-Santiago B.

Microb Pathog. 2016 Aug;97:148-53. doi: 10.1016/j.micpath.2016.06.002. Epub 2016 Jun 2.

PMID:
27263098
16.

Evidence of sexual dimorphism in placental vitamin D metabolism: Testosterone inhibits calcitriol-dependent cathelicidin expression.

Olmos-Ortiz A, García-Quiroz J, López-Marure R, González-Curiel I, Rivas-Santiago B, Olivares A, Avila E, Barrera D, Halhali A, Caldiño F, Larrea F, Díaz L.

J Steroid Biochem Mol Biol. 2016 Oct;163:173-82. doi: 10.1016/j.jsbmb.2016.05.017. Epub 2016 May 19.

PMID:
27210415
17.

Calcitriol prevents inflammatory gene expression in macrovascular endothelial cells.

Gonzalez-Curiel I, Marin-Luevano P, Trujillo V, Enciso-Moreno JA, Gonzalez-Castillo C, Rivas-Santiago B.

Br J Biomed Sci. 2016;73(2):74-8. doi: 10.1080/09674845.2016.1162376. Epub 2016 Apr 8.

PMID:
27181168
18.

Peptides from the scorpion Vaejovis punctatus with broad antimicrobial activity.

Ramírez-Carreto S, Jiménez-Vargas JM, Rivas-Santiago B, Corzo G, Possani LD, Becerril B, Ortiz E.

Peptides. 2015 Nov;73:51-9. doi: 10.1016/j.peptides.2015.08.014. Epub 2015 Sep 4.

PMID:
26352292
19.

LL-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages.

Torres-Juarez F, Cardenas-Vargas A, Montoya-Rosales A, González-Curiel I, Garcia-Hernandez MH, Enciso-Moreno JA, Hancock RE, Rivas-Santiago B.

Infect Immun. 2015 Dec;83(12):4495-503. doi: 10.1128/IAI.00936-15. Epub 2015 Sep 8.

20.

Human neutrophil peptide-1 decreases during ageing in selected Mexican population.

Rivas-Santiago B, Castañeda-Delgado JE, de Haro-Acosta J, Torres-Juarez F, Frausto-Lujan I, Marin-Luevano P, González-Amaro R, Enciso-Moreno JA.

Immunol Res. 2016 Apr;64(2):445-54. doi: 10.1007/s12026-015-8689-2.

PMID:
26323500
21.

Prophylactic potential of defensins and L-isoleucine in tuberculosis household contacts: an experimental model.

Rivas-Santiago B, Rivas-Santiago C, Sada E, Hernández-Pando R.

Immunotherapy. 2015;7(3):207-13. doi: 10.2217/imt.14.119.

PMID:
25804474
22.

Seropositivity for ascariosis and toxocariosis and cytokine expression among the indigenous people in the Venezuelan Delta region.

Araujo Z, Brandes S, Pinelli E, Bochichio MA, Palacios A, Wide A, Rivas-Santiago B, Jiménez JC.

Rev Inst Med Trop Sao Paulo. 2015 Jan-Feb;57(1):47-55. doi: 10.1590/S0036-46652015000100007.

23.

1,25-dihydroxyvitamin D3 induces LL-37 and HBD-2 production in keratinocytes from diabetic foot ulcers promoting wound healing: an in vitro model.

Gonzalez-Curiel I, Trujillo V, Montoya-Rosales A, Rincon K, Rivas-Calderon B, deHaro-Acosta J, Marin-Luevano P, Lozano-Lopez D, Enciso-Moreno JA, Rivas-Santiago B.

PLoS One. 2014 Oct 22;9(10):e111355. doi: 10.1371/journal.pone.0111355. eCollection 2014.

24.

Expression kinetics of metalloproteinases and their tissue inhibitors in experimental murine pulmonary tuberculosis.

Ramos-Martínez AG, Enciso-Moreno JA, Espinosa-Ayala I, Mata-Espinoza D, Rivas-Santiago B, Trujillo-Paez V, Monárrez-Espino J, Hernández-Pando R, Serrano CJ.

Exp Lung Res. 2015 Feb;41(1):1-11. doi: 10.3109/01902148.2014.956946. Epub 2014 Oct 2.

PMID:
25275921
25.

Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.

López-López N, González-Curiel I, Treviño-Santa Cruz MB, Rivas-Santiago B, Trujillo-Paez V, Enciso-Moreno JA, Serrano CJ.

Arch Dermatol Res. 2014 Nov;306(9):809-21. doi: 10.1007/s00403-014-1494-2. Epub 2014 Aug 29.

PMID:
25168880
26.

Characterization of antibacterial and hemolytic activity of synthetic pandinin 2 variants and their inhibition against Mycobacterium tuberculosis.

Rodríguez A, Villegas E, Montoya-Rosales A, Rivas-Santiago B, Corzo G.

PLoS One. 2014 Jul 14;9(7):e101742. doi: 10.1371/journal.pone.0101742. eCollection 2014.

27.

Vitamin D supplementation promotes macrophages' anti-mycobacterial activity in type 2 diabetes mellitus patients with low vitamin D receptor expression.

Lopez-Lopez N, Gonzalez-Curiel I, Castañeda-Delgado J, Montoya-Rosales A, Gandara-Jasso B, Enciso-Moreno JA, Rivas-Santiago B.

Microbes Infect. 2014 Sep;16(9):755-61. doi: 10.1016/j.micinf.2014.06.010. Epub 2014 Jul 9.

PMID:
25016144
28.

Tuberculin skin test and interferon-gamma release assay values are associated with antimicrobial peptides expression in  polymorphonuclear cells during latent tuberculous infection.

Castañeda-Delgado JE, Cervantes-Villagrana A, Serrano-Escobedo CJ, Frausto-Lujan I, Rivas-Santiago C, Enciso-Moreno JA, Rivas-Santiago B.

Mem Inst Oswaldo Cruz. 2014 Jun;109(3):330-4.

29.

Novel approaches to tuberculosis prevention: DNA vaccines.

Rivas-Santiago B, Cervantes-Villagrana AR.

Scand J Infect Dis. 2014 Mar;46(3):161-8. doi: 10.3109/00365548.2013.871645. Epub 2014 Jan 23. Review.

PMID:
24450840
30.

Immunotherapy for pulmonary TB: antimicrobial peptides and their inducers.

Rivas-Santiago CE, Hernández-Pando R, Rivas-Santiago B.

Immunotherapy. 2013 Oct;5(10):1117-26. doi: 10.2217/imt.13.111. Review.

PMID:
24088080
31.

Production of antimicrobial peptides is preserved in aging.

Castañeda-Delgado JE, Miranda-Castro NY, González-Amaro R, González-Curiel I, Montoya-Rosales A, Rivas-Calderon B, Rivas-Santiago B.

Clin Immunol. 2013 Aug;148(2):198-205. doi: 10.1016/j.clim.2013.05.015. Epub 2013 May 31.

PMID:
23770629
32.

Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.

Rivas-Santiago B, Castañeda-Delgado JE, Rivas Santiago CE, Waldbrook M, González-Curiel I, León-Contreras JC, Enciso-Moreno JA, del Villar V, Mendez-Ramos J, Hancock RE, Hernandez-Pando R.

PLoS One. 2013;8(3):e59119. doi: 10.1371/journal.pone.0059119. Epub 2013 Mar 21.

33.

Bacterial expression and antibiotic activities of recombinant variants of human β-defensins on pathogenic bacteria and M. tuberculosis.

Corrales-Garcia L, Ortiz E, Castañeda-Delgado J, Rivas-Santiago B, Corzo G.

Protein Expr Purif. 2013 May;89(1):33-43. doi: 10.1016/j.pep.2013.02.007. Epub 2013 Mar 1.

PMID:
23459290
34.

Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model.

Cervantes-Villagrana AR, Hernández-Pando R, Biragyn A, Castañeda-Delgado J, Bodogai M, Martínez-Fierro M, Sada E, Trujillo V, Enciso-Moreno A, Rivas-Santiago B.

Vaccine. 2013 Jan 11;31(4):676-84. doi: 10.1016/j.vaccine.2012.11.042. Epub 2012 Nov 26.

35.

Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis.

Rivas-Santiago B, Rivas Santiago CE, Castañeda-Delgado JE, León-Contreras JC, Hancock RE, Hernandez-Pando R.

Int J Antimicrob Agents. 2013 Feb;41(2):143-8. doi: 10.1016/j.ijantimicag.2012.09.015. Epub 2012 Nov 8.

PMID:
23141114
36.

Expression of beta defensin 2 in experimental pulmonary tuberculosis: tentative approach for vaccine development.

Rivas-Santiago B, Cervantes-Villagrana A, Sada E, Hernández-Pando R.

Arch Med Res. 2012 May;43(4):324-8. doi: 10.1016/j.arcmed.2012.06.005. Epub 2012 Jun 15.

PMID:
22705089
37.

Patients exposed to Mycobacterium tuberculosis infection with a prominent IgE response.

Araujo Z, Giampietro F, Rivas-Santiago B, Luna-Herrera J, Wide A, Clark W, de Waard JH.

Arch Med Res. 2012 Apr;43(3):225-32. doi: 10.1016/j.arcmed.2012.04.002. Epub 2012 May 5.

PMID:
22564424
38.

[Antimicrobial peptides: a potential arsenal against HIV infection].

Castañeda-Delgado JE, Cervantes-Villagrana AR, Rivas-Santiago B.

Invest Clin. 2012 Mar;53(1):71-83. Review. Spanish.

PMID:
22524110
39.

Mycobacterium tuberculosis complex detected by modified fluorescent in situ hybridization in lymph nodes of clinical samples.

Rodriguez-Nuñez J, Avelar FJ, Marquez F, Rivas-Santiago B, Quiñones C, Guerrero-Barrera AL.

J Infect Dev Ctries. 2012 Jan 12;6(1):58-66.

40.

Expression of antimicrobial peptides in diabetic foot ulcer.

Rivas-Santiago B, Trujillo V, Montoya A, Gonzalez-Curiel I, Castañeda-Delgado J, Cardenas A, Rincon K, Hernandez ML, Hernández-Pando R.

J Dermatol Sci. 2012 Jan;65(1):19-26. doi: 10.1016/j.jdermsci.2011.09.013. Epub 2011 Oct 17.

PMID:
22047630
41.

Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus.

Gonzalez-Curiel I, Castañeda-Delgado J, Lopez-Lopez N, Araujo Z, Hernandez-Pando R, Gandara-Jasso B, Macias-Segura N, Enciso-Moreno A, Rivas-Santiago B.

Hum Immunol. 2011 Aug;72(8):656-62. doi: 10.1016/j.humimm.2011.03.027. Epub 2011 Apr 15.

PMID:
21539878
42.

Induction of β-defensins by l-isoleucine as novel immunotherapy in experimental murine tuberculosis.

Rivas-Santiago CE, Rivas-Santiago B, León DA, Castañeda-Delgado J, Hernández Pando R.

Clin Exp Immunol. 2011 Apr;164(1):80-9. doi: 10.1111/j.1365-2249.2010.04313.x. Epub 2011 Jan 14.

43.

In vitro levels of cytokines in response to purified protein derivative (PPD) antigen in a population with high prevalence of pulmonary tuberculosis.

Giampietro F, de Waard JH, Rivas-Santiago B, Enciso-Moreno JA, Salgado A, Araujo Z.

Hum Immunol. 2010 Nov;71(11):1099-104. doi: 10.1016/j.humimm.2010.07.006. Epub 2010 Aug 2.

PMID:
20650294
44.

Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Castañeda-Delgado J, Hernández-Pando R, Serrano CJ, Aguilar-León D, León-Contreras J, Rivas-Santiago C, Méndez R, González-Curiel I, Enciso-Moreno A, Rivas-Santiago B.

Clin Exp Immunol. 2010 Sep;161(3):542-50. doi: 10.1111/j.1365-2249.2010.04199.x.

45.

[Nicotine as an antidepressant and regulator of sleep in subjects with depression].

Vieyra-Reyes P, Venebra-Muñoz A, Rivas-Santiago B, García-García F.

Rev Neurol. 2009 Dec 16-31;49(12):661-7. Review. Spanish.

46.

Susceptibility to infectious diseases based on antimicrobial peptide production.

Rivas-Santiago B, Serrano CJ, Enciso-Moreno JA.

Infect Immun. 2009 Nov;77(11):4690-5. doi: 10.1128/IAI.01515-08. Epub 2009 Aug 24. Review.

47.

Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains.

Muñoz S, Rivas-Santiago B, Enciso JA.

Scand J Immunol. 2009 Sep;70(3):256-63. doi: 10.1111/j.1365-3083.2009.02295.x.

48.

[Immunitary response in tuberculosis and the role of Mycobacterium tuberculosis secretion antigens in its protection, pathology and diagnosis. Review].

Araujo Z, Acosta M, Escobar H, Baños R, Fernández de Larrea C, Rivas-Santiago B.

Invest Clin. 2008 Sep;49(3):411-41. Review. Spanish.

PMID:
18846780
49.

[Toll-like receptor in lung response to pathogens].

Rivas-Santiago B, Juárez E.

Rev Invest Clin. 2007 Nov-Dec;59(6):481-8. Review. Spanish.

PMID:
18402340
50.

The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis.

Rivas-Santiago B, Contreras JC, Sada E, Hernández-Pando R.

Scand J Immunol. 2008 May;67(5):448-52. doi: 10.1111/j.1365-3083.2008.02088.x. Epub 2008 Mar 18.

Supplemental Content

Loading ...
Support Center